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Background
In the light of an aging HIV population and improved HIV
treatment, Chronic Kidney Disease (CKD) has become a
common contributor to morbidity and mortality. Despite
that the management of CKD in HIV patients is a growing
priority, little is known about the impact of HIV infection
on CKD therapy adherence [1]. To investigate adherence
to CKD medications and antiretroviral (ARV) medications
in patients with co-morbid HIV infection and CKD - in
order to identify modifiable predictors of dual adherence,
focusing on illness representation and medication beliefs.
Methods
This is a qualitative cross-sectional study that prospec-
tively measures the relationship between disease percep-
tions and adherence using self-report instruments and the
electronic Medication Event Monitoring System (MEMS).
HIV viral loads were used as surrogate markers to vali-
date self-reported adherence to ARV medications. Depres-
sion, self-efficacy, alcohol and substance abuse and health
literacy were assessed [2]. 20 well-characterized patients
with CKD/ESRD and HIV were recruited.Institutional
Review Board (IRB) approval was granted. Consent and
confidentiality were protected under the Health Insurance
Portability and Accountability Act (HIPAA).
Results
(I) Demographics Data: Gender, language, ethnicity, race,
education, income marital status and disease precedence
did not affect adherence. Higher comorbidity and pill bur-
den correlated with dual non-adherence. (II) Adherence
Data: 65% of participants reported dual adherence,
15% reported mono-adherence and 20% reported non-
adherence. ARV self-reported adherence correlated with
viral load and CD4+ counts. (III) Barriers & Facilitators of
Adherence: Higher self-efficacy, care satisfaction and trust
in physician correlated with adherence. Depression, smok-
ing, psychiatric illness, alcohol or substance abuse corre-
lated with dual non-adherence. (IV) HIV & CKD Illness
Perceptions: Negative disease perceptions such as stigma
and guilt correlated with non-adherence. (V) Medication
Beliefs: Negative medication beliefs were more prevalent
among ARV non-adherent patients. Adherence was higher
in patients that reported better understanding of disease
and medication.
Conclusion
The majority of participants perceived CKD to be their
main health concern possibly because CKD improvement
requires a combination of lifestyle modifications and
medication adherence [3].
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